Life Tech’s Mass-Spec Revenue Falls 12 Percent in Q2; Total Receipts Rise 2 Percent

Including the effects of currency exchange, the mass spec business fell 15 percent year over year — the steepest decline among the company’s four divisions.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.